Kallikrein-related peptidase 7 overexpression in melanoma cells modulates cell adhesion leading to a malignant phenotype

References

Borgono, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4, 876–890.10.1038/nrc1474Search in Google Scholar PubMed

Brattsand, M., Stefansson, K., Lundh, C., Haasum, Y., and Egelrud, T. (2005). A proteolytic cascade of kallikreins in the stratum corneum. J. Invest. Dermatol. 124, 198–203.10.1111/j.0022-202X.2004.23547.xSearch in Google Scholar PubMed

Caubet, C., Jonca, N., Brattsand, M., Guerrin, M., Bernard, D., Schmidt, R., Egelrud, T., Simon, M., and Serre G. (2004). Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J. Invest. Dermatol. 122, 1235–1244.10.1111/j.0022-202X.2004.22512.xSearch in Google Scholar PubMed

Delaunay, T., Deschamps, L., Haddada, M., Walker, F., Soosaipillai, A., Soualmia, F., El Amri, C., Diamandis, E., Brattsand, M., Magdolen, V., et al. (2017). Aberrant expression of kallikrein-related peptidase 7 is correlated to human melanoma aggressiveness by stimulating cell migration and invasion. Mol. Oncol. 10, 1330–1347.10.1002/1878-0261.12103Search in Google Scholar PubMed PubMed Central

Devetzi, M., Trangas, T., Scorilas, A., Xynopoulos, D., and Talieri, M. (2013). Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7KLK14) in colon cancer. Thromb. Haemost. 109, 716–725.10.1160/TH12-07-0518Search in Google Scholar PubMed

Dong, Y., Loessner, D., Irving-Rodgers, H., Obermair, A., Nicklin, J.L., and Clements, J.A. (2014). Metastasis of ovarian cancer is mediated by kallikrein related peptidases. Clin. Exp. Metastasis 31, 135–147.10.1007/s10585-013-9615-4Search in Google Scholar PubMed PubMed Central

Fischer, J. and Meyer-Hoffert, U. (2013). Regulation of kallikrein-related peptidases in the skin – from physiology to diseases to therapeutic options. Thromb. Haemost. 110, 442–449.10.1160/TH12-11-0836Search in Google Scholar PubMed

Furio, L., Pampalakis, G., Michael, I.P., Nagy, A., Sotiropoulou, G., and Hovnanian, A. (2015). KLK5 inactivation reverses cutaneous hallmarks of Netherton syndrome. PLoS Genet. 11, e1005389.10.1371/journal.pgen.1005389Search in Google Scholar PubMed PubMed Central

Gabril, M., White, N.M., Moussa, M., Chow, T.F., Metias, S.M., Fatoohi, E., and Yousef, G.M. (2010). Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors: potential clinical implications. Biol. Chem. 391, 403–409.10.1515/bc.2010.025Search in Google Scholar PubMed

Ganguly, K.K., Pal, S., Moulik, S., and Chatterjee, A. (2013). Integrins and metastasis. Cell Adh. Migr. 7, 251–261.10.4161/cam.23840Search in Google Scholar PubMed PubMed Central

Gratio, V., Beaufort, N., Seiz, L., Maier, J., Virca, G.D., Debela, M., Grebenchtchikov, N., Magdolen, V., and Darmoul, D. (2010). Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells. Am. J. Pathol. 176, 1452–1461.10.2353/ajpath.2010.090523Search in Google Scholar PubMed PubMed Central

Gratio, V., Loriot, C., Virca, G.D., Oikonomopoulou, K., Walker, F., Diamandis, E.P., Hollenberg, M.D., and Darmoul, D. (2011). Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells. Am. J. Pathol. 179, 2625–2636.10.1016/j.ajpath.2011.07.016Search in Google Scholar PubMed PubMed Central

Haass, N.K. and Herlyn, M. (2005). Normal human melanocyte homeostasis as a paradigm for understanding melanoma. J. Invest. Dermatol. Symp. Proc. 10, 153–163.10.1111/j.1087-0024.2005.200407.xSearch in Google Scholar PubMed

Hatano, Y., Adachi, Y., Elias, P.M., Crumrine, D., Sakai, T., Kurahashi, R., Katagiri, K., and Fujiwara, S. (2013). The Th2 cytokine, interleukin-4, abrogates the cohesion of normal stratum corneum in mice: implications for pathogenesis of atopic dermatitis. Exp. Dermatol. 22, 30–35.10.1111/exd.12047Search in Google Scholar PubMed

Holzscheiter, L., Biermann, J.C., Kotzsch, M., Prezas, P., Farthmann, J., Baretton, G., Luther, T., Tjan-Heijnen, V.C., Talieri, M., Schmitt, M., et al. (2006). Quantitative reverse transcription-PCR assay for detection of mRNA encoding full-length human tissue kallikrein 7: prognostic relevance of KLK7 mRNA expression in breast cancer. Clin. Chem. 52, 1070–1079.10.1373/clinchem.2005.065599Search in Google Scholar PubMed

Iakovlev, V., Siegel, E., Tsao, M., and Haun, R. (2012). Expression of kallikrein-related peptidase 7 predicts poor prognosis in patients with unresectable pancreatic ductal adenocarcinoma. Cancer Epidemiol. Biomarkers Prev. 21, 1135–1142.10.1158/1055-9965.EPI-11-1079Search in Google Scholar PubMed

Johnson, S.K., Ramani, V.C., Hennings, L., and Haun, R.S. (2007). Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin. Cancer 109, 1811–1820.10.1002/cncr.22606Search in Google Scholar PubMed

Kasparek, P., Ileninova, Z., Zbodakova, O., Kanchev, I., Benada, O., Chalupsky, K., Brattsand, M., Beck, I.M., and Sedlacek, R. (2017). KLK5 and KLK7 ablation fully rescues lethality of Netherton syndrome-like phenotype. PLoS Genet. 13, e1006566.10.1371/journal.pgen.1006566Search in Google Scholar PubMed PubMed Central

Komatsu, N., Saijoh, K., Kuk, C., Shirasaki, F., Takehara, K., and Diamandis, E.P. (2007). Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy. Br. J. Dermatol. 156, 875–883.10.1111/j.1365-2133.2006.07743.xSearch in Google Scholar PubMed

Kontos, C.K. and Scorilas, A. (2012). Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers. Clin. Chem. Lab. Med. 50, 1877–1891.10.1515/cclm-2012-0247Search in Google Scholar PubMed

Krenzer, S., Peterziel, H., Mauch, C., Blaber, S.I., Blaber, M., Angel, P., and Hess, J. (2011). Expression and function of the kallikrein-related peptidase 6 in the human melanoma microenvironment. J. Invest. Dermatol. 131, 2281–2288.10.1038/jid.2011.190Search in Google Scholar PubMed PubMed Central

Kryza, T., Silva, M.L., Loessner, D., Heuze-Vourc’h, N., and Clements, J.A. (2016). The kallikrein-related peptidase family: dysregulation and functions during cancer progression. Biochimie 122, 283–299.10.1016/j.biochi.2015.09.002Search in Google Scholar PubMed

Landreville, S., Vigneault, F., Bergeron, M.A., Leclerc, S., Gaudreault, M., Morcos, M., Mouriaux, F., Salesse, C., and Guérin, S.L. (2011). Suppression of alpha5 gene expression is closely related to the tumorigenic properties of uveal melanoma cell lines. Pigment Cell Melanoma Res. 24, 643–655.10.1111/j.1755-148X.2011.00869.xSearch in Google Scholar PubMed

Lei, X., Guan, C.-W., Song, Y., and Wang, H. (2015). The multifaceted role of CD146/MCAM in the promotion of melanoma progression. Cancer Cell Int. 15, 3–11.10.1186/s12935-014-0147-zSearch in Google Scholar PubMed PubMed Central

Loessner, D., Quent, V.M., Kraemer, J., Weber, E.C., Hutmacher, D.W., Magdolen, V., and Clements, J.A. (2012). Combined expression of KLK4, KLK5, KLK6, and KLK7 by ovarian cancer cells leads to decreased adhesion and paclitaxel-induced chemoresistance. Gynecol. Oncol. 127, 569–578.10.1016/j.ygyno.2012.09.001Search in Google Scholar PubMed

Martins, W.K., Esteves, G.H., Almeida, O.M., Rezze, G.G., Landman, G., Marques, S.M., Carvalho, A.F., L Reis, L.F., Duprat, J.P., and Stolf, B.S. (2011). Gene network analyses point to the importance of human tissue kallikreins in melanoma progression. BMC Med. Genomics 4, 76.10.1186/1755-8794-4-76Search in Google Scholar PubMed PubMed Central

McGary, E.C., Lev, D.C., and Bar-Eli, M. (2002). Cellular adhesion pathways and metastatic potential of human melanoma. Cancer Biol. Ther. 1, 459–465.10.4161/cbt.1.5.158Search in Google Scholar PubMed

Mills, L., Tellez, C., Huang, S., Baker, C., McCarty, M., Green, L., Gudas, J.M., Feng, X., and Bar-Eli, M. (2002). Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma. Cancer Res. 62, 5106–5114.Search in Google Scholar

Oikonomopoulou, K., Hansen, K.K., Saifeddine, M., Tea, I., Blaber, M., Blaber, S.I., Scarisbrick, I., Andrade-Gordon, P., Cottrell, G.S., Bunnett, N.W., et al. (2006). Proteinase-activated receptors, targets for kallikrein signaling. J. Biol. Chem. 281, 32095–32112.10.1074/jbc.M513138200Search in Google Scholar PubMed

Pinon, P. and Wehrle-Haller, B. (2010). Integrins: versatile receptors controlling melanocyte adhesion, migration and proliferation. Pigment Cell Melanoma Res. 24, 282–294.10.1111/j.1755-148X.2010.00806.xSearch in Google Scholar PubMed

Postovit, L.M., Seftor, E.A., Seftor, R.E., and Hendrix, M.J. (2006). Influence of the microenvironment on melanoma cell fate determination and phenotype. Cancer Res. 66, 7833–7836.10.1158/0008-5472.CAN-06-0731Search in Google Scholar PubMed

Raju, I., Kaushal, G.P., and Haun, R.S. (2016). Epigenetic regulation of KLK7 gene expression in pancreatic and cervical cancer cells. Biol. Chem. 397, 1135–1146.10.1515/hsz-2015-0307Search in Google Scholar PubMed

Ramani, V.C. and Haun, R.S. (2008a). Expression of kallikrein 7 diminishes pancreatic cancer cell adhesion to vitronectin and enhances urokinase-type plasminogen activator receptor shedding. Pancreas 37, 399–404.10.1097/MPA.0b013e31817f76f7Search in Google Scholar PubMed

Ramani, V.C. and Haun, R.S. (2008b). The extracellular matrix protein fibronectin is a substrate for kallikrein 7. Biochem. Biophys. Res. Commun. 369, 1169–1173.10.1016/j.bbrc.2008.03.021Search in Google Scholar PubMed

Ramsay, A.J., Reid, J.C., Adams, M.N., Samaratunga, H., Dong, Y., Clements, J.A., and Hooper, J.D. (2008). Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs). Biol. Chem. 389, 653–668.10.1515/BC.2008.078Search in Google Scholar PubMed

Rezze, G.G., Fregnani, J.H., Duprat, J., and Landman, G. (2011). Cell adhesion and communication proteins are differentially expressed in melanoma progression model. Hum. Pathol. 42, 409–418.10.1016/j.humpath.2010.09.004Search in Google Scholar PubMed

Sevenich, L. and Joyce, J.A. (2014). Pericellular proteolysis in cancer. Genes. Dev. 28, 2331–2347.10.1101/gad.250647.114Search in Google Scholar PubMed PubMed Central

Sotiropoulou, G., Pampalakis, G., and Diamandis, E.P. (2009). Functional roles of human kallikrein-related peptidases. J. Biol. Chem. 284, 32989–32994.10.1074/jbc.R109.027946Search in Google Scholar PubMed PubMed Central

Stefanini, A.C., da Cunha, B.R., Henrique, T., and Tajara, E.H. (2015). Involvement of kallikrein-related peptidases in normal and pathologic processes. Dis. Markers 2015, 946572.10.1155/2015/946572Search in Google Scholar PubMed PubMed Central

Winnepenninckx, V., Lazar, V., Michiels, S., Dessen, P., Stas, M., Alonso, S.R., Avril, M.F., Ortiz Romero, P.L., Robert, T., Balacescu, O., et al. (2006). Gene expression profiling of primary cutaneous melanoma and clinical outcome. J. Natl. Cancer Inst. 98, 472–482.10.1093/jnci/djj103Search in Google Scholar PubMed

Yang, X., Xuan, Q., Mo, L., Huang, F., Pang, Y., He, M., Lin, W., Li, Q.Q., and Mo, Z. (2010). Differential expression of genes in co-cultured versus separately cultured fibroblasts and epithelial cells from human benign hyperplastic prostate tissues. Int. J. Mol. Med. 26, 17–25.10.3892/ijmm_00000429Search in Google Scholar

Yousef, G.M., Polymeris, M.E., Yacoub, G.M., Scorilas, A., Soosaipillai, A., Popalis, C., Fracchioli, S., Katsaros, D., and Diamandis, E.P. (2003). Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Res. 63, 2223–2227.Search in Google Scholar